State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang
Chen-Yuan
CY
D000995:Antitubercular Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000382:microbiology / Q000635:transmission; D024841:Fluoroquinolones / Q000627:therapeutic use*; D005838:Genotype; D006801:Humans; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D010641:Phenotype; D017410:Practice Guidelines as Topic; D017211:Treatment Failure; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology / Q000635:transmission; D014774:Virulence
D000995:Antitubercular Agents; D024841:Fluoroquinolones